Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04729387
Title Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | SVK | NLD | ITA | GBR | FRA | FIN | ESP | DNK | DEU | CZE | CAN | BRA | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
Arizona Oncology Associates SC Phoenix Arizona 85016 United States Details
HonorHealth Phoenix Arizona 85016 United States Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Florida Cancer Specialists West Palm Beach Florida 33401 United States Details
Maryland Oncology Hematology P A . Silver Spring Maryland 20904 United States Details
Massachusetts General Hospital Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute . Boston Massachusetts 02115 United States Details
Memorial Sloan Kettering Cancer Ctr . New York New York 10065 United States Details
Oncology Hematology Care Inc Cincinnati Ohio 45242 United States Details
University Of Cincinnati Dept of Oncology Cincinnati Ohio 45267 United States Details
Avera Cancer Institute Sioux Falls South Dakota 57106 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Texas Oncology P A Texas Oncology - South Austin Bedford Texas 76022 United States Details
Texas Oncology Charles A. Sammons Cancer Ctr Dallas Texas 75246 United States Details
Texas Oncology P A . San Antonio Texas 78217 United States Details
Texas Oncology Northeast Texas Tyler Texas 75702 United States Details
Novartis Investigative Site Caba Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Ciudad Autonoma de Bs As Buenos Aires C1015ABO Argentina Details
Novartis Investigative Site Buenos Aires C1012AAR Argentina Details
Novartis Investigative Site Randwick New South Wales 2031 Australia Details
Novartis Investigative Site Bedford Park South Australia 5041 Australia Details
Novartis Investigative Site Shepparton Victoria 3630 Australia Details
Novartis Investigative Site Sydney 2031 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Namur 5000 Belgium Details
Novartis Investigative Site Belo Horizonte Minas Gerais 30130-100 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site London Ontario N6A 5W9 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Chengdu Sichuan 610041 China Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Jinan 250012 China Details
Novartis Investigative Site Shanghai 200032 China Details
Novartis Investigative Site Tianjin 300480 China Details
Novartis Investigative Site Novy Jicin Czech Republic 74101 Czechia Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Praha 2 128 51 Czechia Details
Novartis Investigative Site Praha 12808 Czechia Details
Novartis Investigative Site Herlev 2730 Denmark Details
Novartis Investigative Site Odense C DK 5000 Denmark Details
Novartis Investigative Site Kuopio FIN-70211 Finland Details
Novartis Investigative Site Tampere FIN-33521 Finland Details
Novartis Investigative Site Turku FIN 20521 Finland Details
Novartis Investigative Site Besancon Cedex 25030 France Details
Novartis Investigative Site Besancon 25030 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Paris 75012 France Details
Novartis Investigative Site Pierre Benite 69495 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Mannheim Baden Wuerttemberg 68305 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Roma RM 8-00168 Italy Details
Novartis Investigative Site Vicenza VI 36100 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Kota Kinabalu Sabah 88996 Malaysia Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Kuala Lumpur Wilayah Persekutuan 50586 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Monterrey Nuevo Leon 64460 Mexico Details
Novartis Investigative Site Ciudad de Mexico 04700 Mexico Details
Novartis Investigative Site Eindhoven 5623 EJ Netherlands Details
Novartis Investigative Site Loures 2674514 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Bratislava Slovak Republic 83310 Slovakia Details
Novartis Investigative Site Bratislava 83310 Slovakia Details
Novartis Investigative Site Cordoba Andalucia 14004 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Pamplona Navarra 31008 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Taichung 40705 Taiwan Details
Novartis Investigative Site Taichung 407219 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taipei 11217 Taiwan Details
Novartis Investigative Site Adana 01160 Turkey Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Ankara 06230 Turkey Details
Novartis Investigative Site Ankara 06520 Turkey Details
Novartis Investigative Site Izmir 35575 Turkey Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site London SE1 9RT United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field